West Pharmaceutical Services Inc

WST

248.950USD

+17.330+7.48%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

West Pharmaceutical Services Inc's Score

Industry at a Glance

Industry Ranking

19 / 205

Overall Ranking

99 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

West Pharmaceutical Services Inc Highlights

StrengthsRisks

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.08%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.08%.

Undervalued

The company’s latest PE is 36.66, at a low 3-year percentile range.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 849.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.15.

Analyst Rating

Based on 19 analysts

Buy

Current Rating

340.229

Target Price

+46.89%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of West Pharmaceutical Services Inc is 9.70, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 804.60M, representing a year-over-year increase of 7.73%, while its net profit experienced a year-over-year increase of 2.94%.

Score

Industry at a Glance

Previous score

9.70

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.77

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.94

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.81

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of West Pharmaceutical Services Inc is 4.45, ranking 193 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 36.66, which is 61.35% below the recent high of 59.15 and 19.53% above the recent low of 29.50.

Score

Industry at a Glance

Previous score

4.45

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 19/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of West Pharmaceutical Services Inc is 8.11, ranking 58 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 350.00, with a high of 390.00 and a low of 285.00.

Score

Industry at a Glance

Previous score

8.11

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of West Pharmaceutical Services Inc is 7.32, ranking 39 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 279.06 and the support level at 221.34, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.79

Change

0.53

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of West Pharmaceutical Services Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 100.32%, representing a quarter-over-quarter increase of 2.38%. The largest institutional shareholder is The Vanguard, holding a total of 9.51M shares, representing 13.21% of shares outstanding, with 3.17% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.67M

+4.18%

BlackRock Institutional Trust Company, N.A.

3.79M

+0.18%

State Street Investment Management (US)

3.21M

-1.95%

Artisan Partners Limited Partnership

2.77M

+22.21%

Brown Advisory

2.50M

-17.32%

Walter Scott & Partners Ltd.

1.93M

-12.17%

Geode Capital Management, L.L.C.

1.86M

+1.32%

Van Eck Associates Corporation

1.42M

-4.13%

APG Asset Management N.V.

1.41M

-14.77%

Durable Capital Partners LP

1.17M

+12.68%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of West Pharmaceutical Services Inc is 7.55, ranking 37 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.19. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. West Pharmaceutical Services Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

West Pharmaceutical Services Inc

WST

7.93 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment